Your browser doesn't support javascript.
loading
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls.
Boekhout, A H; Rogiers, A; Jozwiak, K; Boers-Sonderen, M J; van den Eertwegh, A J; Hospers, G A; de Groot, J W B; Aarts, M J B; Kapiteijn, E; Ten Tije, A J; Piersma, D; Vreugdenhil, G; van der Veldt, A A; Suijkerbuijk, K P M; Rozeman, E A; Neyns, B; Janssen, K J; van de Poll-Franse, L V; Blank, C U.
Afiliación
  • Boekhout AH; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Rogiers A; Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.
  • Jozwiak K; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Boers-Sonderen MJ; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
  • van den Eertwegh AJ; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Hospers GA; Amsterdam University Medical Centre, Amsterdam, The Netherlands.
  • de Groot JWB; Department of Medical Oncology, University Medical Centre Groningen, Groningen, The Netherlands.
  • Aarts MJB; Isala Oncology Center, Zwolle, The Netherlands.
  • Kapiteijn E; Department of Medical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Ten Tije AJ; Leiden University Medical Centre, Leiden,The Netherlands.
  • Piersma D; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.
  • Vreugdenhil G; Medical Spectrum Twente, Enschede,The Netherlands.
  • van der Veldt AA; Department of Internal Medicine, Maxima Medical Centre, Eindhoven,The Netherlands.
  • Suijkerbuijk KPM; Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Rozeman EA; Department of Medical Oncology, University Medical Cancer Center, Utrecht, The Netherlands.
  • Neyns B; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Janssen KJ; Universitair Ziekenhuis Brussel, Brussel, Belgium.
  • van de Poll-Franse LV; Bristol-Myers Squibb, Utrecht, The Netherlands.
  • Blank CU; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Acta Oncol ; 60(1): 69-77, 2021 Jan.
Article en En | MEDLINE | ID: mdl-32924708
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Supervivientes de Cáncer / Melanoma Tipo de estudio: Guideline / Qualitative_research Idioma: En Revista: Acta Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Supervivientes de Cáncer / Melanoma Tipo de estudio: Guideline / Qualitative_research Idioma: En Revista: Acta Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article